ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,576Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 2456

$1.16M Total Retail Price of All Prescriptions

Rank: 25 out of 2456

504 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 504 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 504 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 19,893 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
METOPROLOL TARTRATE 950 843 1 10
WARFARIN SODIUM 890 834 2 9
FUROSEMIDE 830 778 3 8
SIMVASTATIN 734 657 4 2
LISINOPRIL 693 627 5 1
LEVOTHYROXINE SODIUM 621 529 6 4
AMLODIPINE BESYLATE 500 461 7 5
OMEPRAZOLE 415 288 8 3
METFORMIN HCL 347 326 9 11
POTASSIUM CHLORIDE 344 322 10 33
CITALOPRAM HBR 335 323 11 14
DONEPEZIL HCL 334 334 12 23
ATENOLOL 294 277 13 6
HYDROCHLOROTHIAZIDE 280 245 14 7
SPIRIVA 265 218 15 43
NAMENDA 252 252 16 42
GABAPENTIN 245 200 17 16
ATORVASTATIN CALCIUM 236 232 18 12
METOPROLOL SUCCINATE 236 225 18 13
GENERLAC 220 220 20 142
TRAZODONE HCL 219 180 21 17
MIRTAZAPINE 213 209 22 29
POLYETHYLENE GLYCOL 3350 202 188 23 64
ADVAIR DISKUS 200 175 24 36
RISPERIDONE 193 193 25 50
TAMSULOSIN HCL 192 180 26 32
LIDODERM 184 178 27 58
ALLOPURINOL 184 182 27 27
ALENDRONATE SODIUM 167 156 29 19
TRAMADOL HCL 166 131 30 24
SERTRALINE HCL 165 126 31 21
HYDROCODONE-ACETAMINOPHEN 155 116 S3 32 20
KLOR-CON M20 150 145 33 69
DIGOXIN 146 138 34 49
PREDNISONE 144 132 35 39
LOVASTATIN 143 119 36 34
CLOZAPINE 142 142 37 75
LANTUS 137 125 38 44
PRAVASTATIN SODIUM 136 129 39 15
FAMOTIDINE 135 112 40 84
PROAIR HFA 134 91 41 22
ISOSORBIDE MONONITRATE ER 132 128 42 48
AZITHROMYCIN 129 110 43 60
IPRATROPIUM-ALBUTEROL 122 120 44 85
CYMBALTA 122 109 44 65
FINASTERIDE 115 103 46 66
FLUOXETINE HCL 112 95 47 45
ZOLPIDEM TARTRATE 109 83 48 28
SULFAMETHOXAZOLE-TRIMETHOPRIM 108 107 49 147
CYCLOBENZAPRINE HCL 108 47 R 49 77
OXYCODONE HCL-ACETAMINOPHEN 106 43 S2 51 101
ROPINIROLE HCL 105 94 52 148
CARBIDOPA-LEVODOPA 105 93 52 82
KLOR-CON 10 105 100 52 133
LACTULOSE 104 96 55 88
LEVOFLOXACIN 103 92 56 103
AMITRIPTYLINE HCL 102 64 R 57 83
OLANZAPINE 101 97 58 57
RANITIDINE HCL 100 99 59 31
DIVALPROEX SODIUM 99 94 60 51
METFORMIN HCL ER 97 97 61 59
JANUVIA 97 97 61 81
OXYCODONE HCL 95 46 S2 63 38
ESCITALOPRAM OXALATE 94 68 64 116
PROPRANOLOL HCL 92 72 65 108
PANTOPRAZOLE SODIUM 92 72 65 37
OXYCONTIN 92 73 S2 65 129
QUETIAPINE FUMARATE 90 81 68 47
ZETIA 87 63 69 86
KLOR-CON M10 87 84 69 196
MECLIZINE HCL 85 60 71 107
CIPROFLOXACIN HCL 84 80 72 87
FENTANYL 83 73 S2 73 115
BUMETANIDE 82 80 74 167
GLIMEPIRIDE 82 82 74 74
DILTIAZEM 24HR ER 80 77 76 78
LOSARTAN POTASSIUM 80 69 76 18
HALOPERIDOL 78 78 78 137
PHENYTOIN SODIUM EXTENDED 76 63 79 140
PRAMIPEXOLE DIHYDROCHLORIDE 76 68 79 330
SYNTHROID 73 62 81 118
VENTOLIN HFA 71 50 82 210
CRESTOR 70 39 83 25
VERAPAMIL ER 68 68 84 91
DILTIAZEM HCL 68 68 84 207
PEN NEEDLE 68 59 84 150
OXYCODONE-ACETAMINOPHEN 65 42 S2 87 35
NIASPAN 65 42 87 181
LEVETIRACETAM 65 64 87 90
EXELON 64 64 90 161
NYSTOP 64 54 90 125
TRIAMCINOLONE ACETONIDE 63 49 92 131
DEXILANT 63 57 92 114
OXYBUTYNIN CHLORIDE ER 63 56 92 94
NIFEDICAL XL 62 62 95 184
VENLAFAXINE HCL ER 62 54 95 92
LANTUS SOLOSTAR 60 56 97 136
SEROQUEL 59 53 98 102
HUMALOG 59 56 98 123
CEPHALEXIN 58 53 100 153
PAROXETINE HCL 58 48 100 56
MORPHINE SULFATE 57 45 S2 102 226
BACLOFEN 56 39 103 112
SYMBICORT 54 54 104 138
NOVOLOG 52 39 105 100
DOXYCYCLINE HYCLATE 52 43 105 166
FENOFIBRATE 52 52 105 68
NITROGLYCERIN PATCH 52 52 105 134
CELEBREX 51 39 109 127
CLOPIDOGREL 51 44 109 55
NOVOLIN R 50 48 111 173
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.